Santa Barbara, CA, United States of America

Hugh L Narciso, Jr


Average Co-Inventor Count = 1.6

ph-index = 22

Forward Citations = 2,737(Granted Patents)


Location History:

  • Santa Barbara, CA (US) (1992 - 2000)
  • Mountain View, CA (US) (1999 - 2003)

Company Filing History:


Years Active: 1992-2003

Loading Chart...
24 patents (USPTO):Explore Patents

Title: Innovations by Hugh L Narciso, Jr: Pioneering Intravascular Devices

Introduction: Hugh L Narciso, Jr., based in Santa Barbara, CA, is a distinguished inventor with a notable portfolio of 24 patents. His contributions significantly advance the field of medical devices, specifically in intravascular technology.

Latest Patents: Among his latest inventions, Hugh has developed a sophisticated intravascular hemostasis device and method. This device features an elongated tubular member with a flexible, deformable sealing member designed to manage hemostasis effectively within blood vessels. The sealing member can transition between a compressed state for insertion and an expanded state to seal against the vessel's inner wall. Additionally, his perfusion-occlusion apparatus allows for controlled occlusion in a vessel while maintaining a pathway for blood perfusion, further facilitating medical procedures such as anastomosis. The catheter aspect of this invention includes a protective shield to prevent damage from suture needles and similar instruments.

Career Highlights: Throughout his career, Hugh has been associated with companies such as PDT Systems, LLC and PDT Cardiovascular, Inc. His work in these organizations has helped drive innovation in cardiovascular interventions and therapeutic solutions.

Collaborations: Hugh L Narciso, Jr. has collaborated with notable professionals in the field, such as Daniel R Doiron and Steven C Anderson. These partnerships reflect a commitment to advancing medical technology and addressing complex health challenges.

Conclusion: Hugh L Narciso, Jr. stands out as an innovator in the field of medical devices, with patents that demonstrate his dedication to improving patient outcomes. His work continues to shape the future of intravascular treatments and enhance the capabilities of medical technologies in the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…